| Serial Number | 79413326 |
| Word Mark | ALLO CHASSIS |
| Filing Date | Wednesday, October 9, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 3, 2026 |
| Goods and Services | Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified iPS cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells iPS cells other than for medical or veterinary use; Biological preparations for use in cell cultures, other than for medical or veterinary purposes, namely, cell culture agents for use in the biotechnology industry and cell material for use in combination with human cells, particularly genetically modified iPS or differentiated stem cells |
| NOT AVAILABLE | "ALLO" |
| Goods and Services | Modified cells, in particular genetically modified iPS (induced pluripotent stem) cells or differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified iPS (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells. |
| Description of Mark | The mark consists of a four point star design outlined by purple lines radiating outward to form a circle and the wording "ALLO CHASSIS" stylized in dark purple. |
| Goods and Services | Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, namely, manufacturing of the foregoing cells in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, namely, manufacturing in GMP-based facilities; custom manufacture of cellular therapies, namely, manufacturing in GMP-based facilities; custom manufacturing of cell lines being modified cells with specific genetic edits for use in generating other cells |
| Goods and Services | Research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified iPS (induced pluripotent stem) cells and differentiated cells derived therefrom; Scientific research, design and development of scientific cell culture, cell therapy and gene edited cell therapy; Scientific research, design and development of cell culture, cell therapy or gene edited cell therapy, manufacturing systems and manufacturing processes for others; platform as a service (PAAS) services featuring computer software platforms for custom manufacturing of cell-based products, in the field of cell therapy, and cell therapy development; providing temporary use of online non-downloadable computer software platform for the management of manufacturing of cell-based therapies, namely, the associated technology, processes, and data analytics capabilities for process optimization and quality control |
| Indication of Colors claimed | The color(s) purple and dark purple is/are claimed as a feature of the mark. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Celyntra Therapeutics SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | BE |
| Party Name | Celyntra Therapeutics SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | BE |
| Event Date | Event Description |
| Thursday, December 26, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, December 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 30, 2024 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 21, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, April 30, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 1, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, July 1, 2025 | REFUSAL PROCESSED BY MPU |
| Tuesday, July 1, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 19, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, December 30, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 30, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 30, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 30, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, January 30, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, January 30, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 5, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 5, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 5, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 6, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 25, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 3, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 3, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |